MyFinsight
Home
Blog
About
Cash and cash
equivalents
$549,769K
(0.68%↑ Y/Y)
Investments, short-term
$118,022K
(513.93%↑ Y/Y)
Trade receivables,
net
$110,995K
(19.37%↑ Y/Y)
Prepaid expenses
$19,311K
(5.16%↑ Y/Y)
Other current assets
$9,877K
(14.37%↑ Y/Y)
Inventory, net
$6,360K
(4.26%↑ Y/Y)
Investments, long-term
$294,668K
(175.37%↑ Y/Y)
Deferred tax asset
$156,765K
(-22.08%↓ Y/Y)
Intangible assets, net
$77,496K
(-23.53%↓ Y/Y)
Other noncurrent
assets
$29,821K
(445.67%↑ Y/Y)
Total current assets
$814,334K
(17.79%↑ Y/Y)
Total noncurrent
assets
$558,750K
(34.10%↑ Y/Y)
Total assets
$1,373,084K
(23.92%↑ Y/Y)
Total liabilities and
stockholders' equity
$1,373,084K
(23.92%↑ Y/Y)
Total stockholders'
equity
$999,243K
(29.25%↑ Y/Y)
Total liabilities
$373,841K
(11.62%↑ Y/Y)
Accumulated other
comprehensive (loss) income
-$727K
(-404.18%↓ Y/Y)
Additional paid in capital
$731,147K
(6.69%↑ Y/Y)
Retained earnings
$268,822K
(207.04%↑ Y/Y)
Total current
liabilities
$234,070K
(29.94%↑ Y/Y)
Total noncurrent
liabilities
$139,771K
(-9.70%↓ Y/Y)
Common stock-0.00001
par value...
$1K
(0.00%↑ Y/Y)
Accrued expenses
$169,128K
(42.97%↑ Y/Y)
Trade payables
$21,684K
(-23.38%↓ Y/Y)
Current portion of
long-term debt
$20,000K
(6.67%↑ Y/Y)
Accrued compensation
$12,091K
(3.03%↑ Y/Y)
Other current
liabilities
$11,167K
(265.41%↑ Y/Y)
Long-term debt, net
$133,961K
(-12.64%↓ Y/Y)
Other noncurrent
liabilities
$5,810K
(301.24%↑ Y/Y)
Back
Back
Balance Sheet
Harmony Biosciences Holdings, Inc. (HRMY)
Harmony Biosciences Holdings, Inc. (HRMY)
source: myfinsight.com